Cargando…

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice

OBJECTIVE: Inflammatory bowel diseases (IBD) have been intrinsically linked to a deregulated cytokine network, but novel therapeutic principles are urgently needed. Here we identify the interleukin (IL)-33 and its receptor ST2 as key negative regulators of wound healing and permeability in the colon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sedhom, Mamdouh A K, Pichery, Mélanie, Murdoch, Jenna R, Foligné, Benoit, Ortega, Nathalie, Normand, Sylvain, Mertz, Kirsten, Sanmugalingam, Devika, Brault, Lea, Grandjean, Teddy, Lefrancais, Emma, Fallon, Padraic G, Quesniaux, Valérie, Peyrin-Biroulet, Laurent, Cathomas, Gieri, Junt, Tobias, Chamaillard, Mathias, Girard, Jean-Philippe, Ryffel, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Experimental Colitis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841767/ https://www.ncbi.nlm.nih.gov/pubmed/23172891 http://dx.doi.org/10.1136/gutjnl-2011-301785

Ejemplares similares

Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions
por: van den Broek, F J C, et al.
Publicado: (2008)

TLR-independent anti-inflammatory function of intestinal epithelial TRAF6 signalling prevents DSS-induced colitis in mice
por: Vlantis, Katerina, et al.
Publicado: (2016)

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
por: Biemans, Vince B. C., et al.
Publicado: (2020)

Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open
por: Panaccione, Remo, et al.
Publicado: (2022)

Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry
por: Straatmijer, Tessa, et al.
Publicado: (2022)

The effectiveness and safety of infliximab compared with biosimilar CT‐P13, in 3112 patients with ulcerative colitis
por: Meyer, Antoine, et al.
Publicado: (2019)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

Unbiased screen for pathogens in human paraffin-embedded tissue samples by whole genome sequencing and metagenomics
por: Nienhold, Ronny, et al.
Publicado: (2022)

Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation
por: Osterman, Mark T., et al.
Publicado: (2019)

Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment
por: Sandborn, William J., et al.
Publicado: (2021)

Intestinal ultrasound detects an increased diameter and submucosal layer thickness in the appendix of patients with ulcerative colitis compared to healthy controls – a prospective cohort study
por: Reijntjes, Maud A., et al.
Publicado: (2022)

The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
por: Mertz, Kirsten D., et al.
Publicado: (2015)

Interleukin-33 in human gliomas: Expression and prognostic significance
por: GRAMATZKI, DOROTHEE, et al.
Publicado: (2016)

Echinococcal hepatic lesion mimicking metastasis from colon cancer: two case reports
por: Cathomas, Marionna, et al.
Publicado: (2021)

Alpha 1-antitrypsin retention in an ectopic liver
por: Dettmer, Matthias, et al.
Publicado: (2011)

Hymenolepis nana: A case report of a perfect IBD camouflage warrior
por: Hench, Juergen, et al.
Publicado: (2017)

The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis
por: Kump, P., et al.
Publicado: (2017)

Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013
por: Shawihdi, Mustafa, et al.
Publicado: (2019)

Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis
por: Rubin, David T., et al.
Publicado: (2021)

Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome
por: Koelzer, Viktor H., et al.
Publicado: (2016)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Calculation of Mercury’s Effects on Neurodevelopment
por: Grandjean, Philippe, et al.
Publicado: (2012)

Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy
por: Koelzer, Viktor H., et al.
Publicado: (2016)

Two distinct immunopathological profiles in autopsy lungs of COVID-19
por: Nienhold, Ronny, et al.
Publicado: (2020)

Will the Quality of Research Remain the Same During the COVID-19 Pandemic?
por: Peyrin-Biroulet, Laurent
Publicado: (2020)

Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis
por: Olaisen, Maya, et al.
Publicado: (2019)

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study
por: Koelzer, Viktor H., et al.
Publicado: (2016)

PRDM Histone Methyltransferase mRNA Levels Increase in Response to Curative Hormone Treatment for Cryptorchidism-Dependent Male Infertility
por: Hadziselimovic, Faruk, et al.
Publicado: (2018)

Herpes simplex virus colitis mimicking acute severe ulcerative colitis: a case report and review of the literature
por: Cathomas, Marionna, et al.
Publicado: (2023)

Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease
por: Abreu, Maria T, et al.
Publicado: (2020)

Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise
por: Danese, Silvio, et al.
Publicado: (2021)

Evolution of IL-23 Blockade in Inflammatory Bowel Disease
por: Danese, Silvio, et al.
Publicado: (2022)

Neutralisation pockets and spectral lines
por: Gröbner, Oswald
Publicado: (1972)

On Toxic Neutralisations: II. Reconstitution
por: Richardson, Benjamin Ward
Publicado: (1894)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

Giant ectopic liver, hepatocellular carcinoma and pachydermia-a rare genetic syndrome?
por: Dettmer, Matthias, et al.
Publicado: (2011)

Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature
por: Fehr, Martin, et al.
Publicado: (2019)

Childhood lead exposure in France: benefit estimation and partial cost-benefit analysis of lead hazard control
por: Pichery, Céline, et al.
Publicado: (2011)

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors
por: Paasinen-Sohns, Aino, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1r0q6jr5epvf97o9puae0kpg4l